Saturday, July 11, 2026

Drug profile · INN

griseofulvin

griseofulvin (GRISOVIN) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — griseofulvin

Quick answer

griseofulvin (GRISOVIN) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN griseofulvin
Brand GRISOVIN
Mechanism Tubulin inhibitor
Target Tubulin

Mechanism of action

Tubulin inhibitor

Primary target: Tubulin

Approval history

Authority Status Date
TGA approved

Related & competitor drugs

  1. brentuximab vedotin Antineoplastic and immunomodulating agents (L01)
  2. cabazitaxel Antineoplastic and immunomodulating agents (L01)
  3. colchicine Musculo-skeletal system (M04)
  4. docetaxel Antineoplastic and immunomodulating agents (L01)
  5. paclitaxel Antineoplastic and immunomodulating agents (L01)
  6. vincristine sulfate Tubulin inhibitor

Frequently asked questions

What is griseofulvin?

griseofulvin (GRISOVIN) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for griseofulvin?

GRISOVIN is a marketed brand name for griseofulvin. Check FDA Drugs@FDA for the current US label holder and prescribing information.